爱博医疗
(688050)
| 流通市值：76.58亿 | | | 总市值：76.58亿 |
| 流通股本：1.93亿 | | | 总股本：1.93亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 932,766,774.39 | 398,242,787.56 | 1,482,702,741.33 | 1,144,414,504.11 |
| 营业总成本 | 728,719,852.45 | 296,089,853.1 | 1,122,004,590.7 | 830,567,968.09 |
| 其他经营收益 | | | | |
| 营业利润 | 211,604,222.72 | 98,744,911.85 | 289,710,022.25 | 322,234,719.04 |
| 利润总额 | 210,391,585.49 | 98,646,072.26 | 289,262,319.37 | 322,404,702.29 |
| 净利润 | 181,240,484.15 | 85,809,044.2 | 240,589,726.7 | 278,623,253.61 |
| 每股收益 | | | | |
| 其他综合收益 | 819,881.95 | 249,408.78 | 376,614.67 | -4,108,010.19 |
| 综合收益总额 | 182,060,366.1 | 86,058,452.98 | 240,966,341.37 | 274,515,243.42 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,869,981,715.88 | 1,941,310,614.31 | 1,670,047,413.34 | 1,587,115,954.59 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,885,541,001.08 | 2,823,594,539.34 | 2,217,827,631.56 | 2,315,867,888.42 |
| 资产总计 | 4,755,522,716.96 | 4,764,905,153.65 | 3,887,875,044.9 | 3,902,983,843.01 |
| 流动负债: | | | | |
| 流动负债合计 | 577,644,907.46 | 623,844,754.43 | 423,752,144.09 | 381,924,111.26 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,030,940,519.75 | 1,014,459,171.46 | 493,893,521.03 | 513,035,973.59 |
| 负债合计 | 1,608,585,427.21 | 1,638,303,925.89 | 917,645,665.12 | 894,960,084.85 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,886,079,126.19 | 2,863,882,904.75 | 2,788,736,482.19 | 2,810,505,035.17 |
| 股东权益合计 | 3,146,937,289.75 | 3,126,601,227.76 | 2,970,229,379.78 | 3,008,023,758.16 |
| 负债和股东权益合计 | 4,755,522,716.96 | 4,764,905,153.65 | 3,887,875,044.9 | 3,902,983,843.01 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 848,838,719.37 | 306,617,605.62 | 1,559,591,302.47 | 1,151,614,975.68 |
| 经营活动现金流出小计 | 728,619,923.44 | 287,913,170.35 | 1,190,444,185.93 | 921,518,444.67 |
| 经营活动产生的现金流量净额 | 120,218,795.93 | 18,704,435.27 | 369,147,116.54 | 230,096,531.01 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 365,297,467.14 | 189,646,298.96 | 1,313,504,732.55 | 1,002,911,806.8 |
| 投资活动现金流出小计 | 974,237,432.84 | 766,223,124.58 | 1,457,467,565.82 | 964,598,369.87 |
| 投资活动产生的现金流量净额 | -608,939,965.7 | -576,576,825.62 | -143,962,833.27 | 38,313,436.93 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 724,144,489.4 | 651,518,956.09 | 327,520,598.99 | 321,989,451.88 |
| 筹资活动现金流出小计 | 260,463,907.31 | 65,347,219.5 | 284,935,921.77 | 272,905,530.5 |
| 筹资活动产生的现金流量净额 | 463,680,582.09 | 586,171,736.59 | 42,584,677.22 | 49,083,921.38 |
| 汇率变动对现金及现金等价物的影响 | -2,673,021.2 | -1,408,974.27 | -1,857,944.59 | -1,291,170.41 |
| 现金及现金等价物净增加额 | -27,713,608.88 | 26,890,371.97 | 265,911,015.9 | 316,202,718.91 |
| 期末现金及现金等价物余额 | 602,095,885.58 | 656,699,866.43 | 629,809,494.46 | 680,101,197.47 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -27,713,608.88 | - | 265,911,015.9 | - |
最新报告期：2026-07-10| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中金公司 | 张一弛,李千翊 | 1.81 | 2.18 | -- | 2026-07-10 |